Fecal microbiota transplants 💩

Season finale alert! 🚨

We're diving into a cutting-edge breakthrough in gut health: Fecal Microbiota transplants (FMT) with an innovative new product soon hitting the market.

Host Ariadna Masó (SANNO founder & CEO) speaks with Patricia del Rio, Director of Business Development at Mikrobiomik, a pioneering biopharma company focused on microbiome-based therapies.

Patricia shares the science behind their FMT capsules, tackling antibiotic resistance and revolutionizing patient care.

Tune in to learn about:

• The fascinating world of the fecal microbiome 🦠

• How FMTs are reshaping treatment for Clostridioides difficile.

• Challenges and promises of microbiome-based therapies 🚀

Get ready to discover how innovation is changing the future of gut health! 🎙️

#GutHealth #Microbiome #FecalMicrobiotaTransplant #HealthInnovation #ClinicalTrials #Healthcare #MicrobiomeTherapies #Podcast #PatientCare #FutureOfMedicine